"An idealist is a person who helps other people to be prosperous."Henry Ford (1863 - 1947)The morality of medical practice is based on beneficence. The benefit is applicable to an
organ, however, it is not enough. The safety of the procedure to the patient's life is a
concern[1].The sense of the usefulness of a therapeutic method is well validated by effect extent
class I/IIa in a guideline, but he/she can be harmed when the unexpected wins
predictability. The high complexity collects unquestionable medical indications that
exhibit poor individual prognosis due to severe comorbidities[2].In this comparison between illness and patient, the contraindication illustrates that the
major limitations of physician are the limits of medical science. Fortunately, we live in a
moment of endless technological innovations. Readily globalized, they expand the skill
bounderies and, at the same time, they give vitality to the classic, for the ongoing
development is imperative in medical science.A new horizon requires interdisciplinarity, which, in turn, demands interpersonal
communication. In the interests of the best clinical practice for the patient, the
propaedeutics communicates with clinical and scientific evidence that is understood as the
clinical reasoning under the tension of the imminence of conduct, listening to the values
and preferences of the patient. The efficient communication - to talk, to hear oneself (am
I being objective?), to listen and to hear oneself hearing (am I connected?) - energizes
the trespassing through the essential ethical tolls: benefit of method, patient safety and
human character of medical science[3].In recent millennium transition, the routine of "discussion of the case" included the gap
between the availability of medical science and medical care to the elderly with aortic
valve stenosis ineligible for conventional surgical treatment. However, already in the
early years of the 21st century, the discomfort of "if we can't do-good, at least let us
not do harm" was reduced by the prospects of support to this subgroup of patients by means
of transcateter implant of a bioprosthesis.Due to the initial results, the sentence has changed, following the change of the paradigm,
to "we can do-good, but we have to take care of its potential harm". The systematized
research[4] proved the positive
impact on the "hard" outcome pro-life and raised the likelihood of the certainty of benefit
to B level. However, the best survival curve does not invalidate the uncertainties of
complications related to innovation, a base of the modern concept of iatrogenesis[5].Bedside conflicts arise between using an alternative method to conventional surgery to
correct aortic valve hemodynamics and, at the same time, envision strong objections to
satisfy the purpose both of survival and quality of life. They direct the physician to
establish the applicable proportions of science and humanism, strongly advised by
soliloquy, with the ontological component of ethics.The "I do-good to the patient because it crops out from being who I am and not just because
I read the code of ethics" makes prudence and zeal flow in
indicating/non-indicating/contraindicating depending on the symbolism of the Hippocratic
oath. The resulting ordering of adjustments to the benefit ensures value for
deliberation.It is worth remembering that, about 20 years ago, this moral plumbing occurred in
establishing balloon catheter of mitral valvuloplasty and encouraged a close and
progressive knowledge feedback and skill on the patient with mitral stenosis. Physician,
surgeon, interventional cardiologist and echocardiographist got together and converted the
field of the then innovation into an efficient relationship benefit/security that made it a
rare AI recommendation in guideline of valvular heart disease. Currently, the transcateter
implant of bioprosthetic in aortic position causes similar mobilization[6]. The search for answers to the questions
brought about by the new therapeutic heritage recommends to appreciate it further than just
a procedure. It is preferable to see it as a program comparable to a transplant[7].The commitment of a collective of experts as far as the learning curve of this change of
therapeutic standard in patients with valvular heart disease is concerned neither plastic
nor native tissue replacement - is better structured in the formation of an
interdisciplinary team to valvular heart disease. The team set-up replaces the one of
disciplinary workgroup enough for sustainable routines by the coldness of reports and the
monologue opinions juxtaposed.The interdisciplinary team for valvular heart disease links space and time. These
dimensions make the refinement of movements and countermovements easier and to support
excellence. Indication/non indication/contraindication may, therefore, be appropriately
customized to the symptomatic elderly with aortic valve stenosis, respecting the enormous
heterogeneity of the real world twinned by right to dignity.Transparency in interdisciplinary coordination of complementary expertises
in patients with valvular heart disease is the raw material for the construction of a
platform of clarity of tasks to be fulfilled, limits to be respected and performance levels
to be achieved. Interdisciplinary meanings for the professional proficiency make the team
an opinion maker.The interdisciplinary team for valvular heart disease confers nationality. The hierarchy
between methods with flexibility in its borders, the tone for subjectivities (body
weakness) and inaccurate objectivities (surgical risk scores), critical analysis on
personal and literature results and the modulation to the sociocultural and economic
develop the necessary fine tuning with Brazilian realities.The interdisciplinary team for valvular heart disease is greater than the sum of their
participants, which does not happen with the working group. The expansion lies in the
attitude of each member - sometimes as a disclosure, other as a receiver. I teach, you
learn, he improves, we progress, is the conjugation intended from a system connected to
attain the highest level of mutual understanding on cost-risk-effectiveness about the
trinomial aortic valve stenosis -non valvular cardiac abnormalities-extra cardiac
comorbidities.The interdisciplinary team to valvular heart disease thrusts the clippings out of interest
the vertical provisions verticalized by the hyperspecialization turns to a horizontal
solidarity position between one another, useful for the needs, preferences ad values of the
Brazilian elderlyThe interdisciplinary team for valvular heart disease highlights the value of current
cardiology as it extracts information from the three imaging giants - ultrasonography, CT
scan and MRI - and introduces it into the hammer of decision making present in the
calloused hands of sovereign clinic, powerful surgical clinic and the skillful
interventionist cardiology.In short, the interdisciplinary team for valvular heart disease builds a strong
interdisciplinarity. When exchanging not only methods but also concepts, the
transdisciplinarity[8] becomes closer
by using rigor together with fundamental concepts, the opening to the unknown and the
tolerance toward the gaps of medical science based on evidence about practices that cannot
be disproved by personal experience. The hybrid room is the emblem.It is known that languages are neither static nor closed. Loan words occur as the result of
dominance over a particular segment of society. In this context, the niche of present
medical science is influenced by the supremacy of English language literature. TAVI is an
anglicism that was quietly incorporated. Just as we should not insist on a Brazilian
acronym by repositioning letters - ITVA or IVAT -, It seems reasonable to us to adopt the
globalized (and synthetic) name Heart Team to express an interdisciplinary team specialized
in cardiology.The concept of Heart Team was revived less than a decade ago as a methodological imperative
deriving from the SYNTAX study[9]. The name
gained notoriety for its contribution to the discipline communication and has migrated from
research to assistance fields. The Heart Team acquired high organizational value in
valvular heart disease, being understood that its absence is an absolute contraindication
to the bioprosthetic transcateter implant in aortic position[10].I propose that the Heart Team expression that (in)vests the shirt on in reliable
relationship in a interdisciplinary network and acquires scientific capital facilitator of
complex deliberations before the symptomatic elderly suffering from aortic valve stenosis
to be termed as Heart Valve Team (VHT).VHT specificity includes: a) bioprosthesis management techniques and improvement ; b)
contributions from imaging methods; c) safety by reducing adversity; d) early and late
results, including participation in records; e) propensity to the use transcateter implant
under minor surgical risk.It is appropriate to emphasize that the VHT should not be viewed with an expiration date to
be set by taking innovation for granted. The VHT means aggregation in favour for excellence
in the attention given to grey areas experienced by patients with valvular heart disease
with dubious issues according to valvular and/or non valvular cardiac and /or extra-cardiac
complexities.Finally, the VHT does not reinvent the wheel. VHT rediscovers the union and the gathering
of people that give vitality to the analysis of uncertainties, the overcoming of adversity
and the extent of the benefit.
Authors: Martin B Leon; Craig R Smith; Michael Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; David L Brown; Peter C Block; Robert A Guyton; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Pamela S Douglas; John L Petersen; Jodi J Akin; William N Anderson; Duolao Wang; Stuart Pocock Journal: N Engl J Med Date: 2010-09-22 Impact factor: 91.245
Authors: John G Webb; Sanjeevan Pasupati; Karin Humphries; Christopher Thompson; Lukas Altwegg; Robert Moss; Ajay Sinhal; Ronald G Carere; Brad Munt; Donald Ricci; Jian Ye; Anson Cheung; Sam V Lichtenstein Journal: Circulation Date: 2007-07-23 Impact factor: 29.690
Authors: Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Iung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala Journal: Eur Heart J Date: 2012-08-24 Impact factor: 29.983
Authors: Brett D Atwater; David Dai; Nancy M Allen-Lapointe; Sana M Al-Khatib; Louise O Zimmer; Gillian D Sanders; Eric D Peterson Journal: Am Heart J Date: 2012-10-16 Impact factor: 4.749